Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ADMA Biologics Inc (ADMA : NSDQ)

• Company Description    ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey. Number of Employees: 647

• Price / Volume Information    Yesterday's Closing Price: $8.27 Daily Weekly Monthly 20 Day Moving Average: 2,889,625 shares Shares Outstanding: 231.77 (millions) Market Capitalization: $1,916.76 (millions) Beta: 0.73 52 Week High: $20.46 52 Week Low: $7.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.16% -5.86% 12 Week -19.32% -21.53% Year To Date -54.66% -57.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 465 STATE ROUTE 17 - RAMSEY,NJ 07446 USA ph: 201-478-5552 fax: 201-478-5553 adma@argotpartners.com http://www.admabiologics.com

• General Corporate Information    Officers Adam S. Grossman - President; Chief Executive Officer and Director Steven A. Elms - Chairman Jerrold B. Grossman - Vice Chairman Brad Tade - Chief Financial Officer Alison Finger - Director Peer Information ADMA Biologics Inc (CORR.) ADMA Biologics Inc (RSPI) ADMA Biologics Inc (CGXP) ADMA Biologics Inc (BGEN) ADMA Biologics Inc (GTBP) ADMA Biologics Inc (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000899104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 231.77 Most Recent Split Date: (:1) Beta: 0.73 Market Capitalization: $1,916.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.80 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 10.29 Trailing 12 Months: 11.81 PEG Ratio: - Price Ratios Price/Book: 4.92 Price/Cash Flow: 12.64 Price / Sales: 3.76 EPS Growth vs. Year Ago Period: 35.71% vs. Previous Quarter: -5.00% Sales Growth vs. Year Ago Period: -0.27% vs. Previous Quarter: -17.73% ROE 06/30/26 - - 03/31/26 - 39.98 12/31/25 - 37.52 ROA 06/30/26 - - 03/31/26 - 28.08 12/31/25 - 27.87 Current Ratio 06/30/26 - - 03/31/26 - 6.95 12/31/25 - 6.71 Quick Ratio 06/30/26 - - 03/31/26 - 3.93 12/31/25 - 3.74 Operating Margin 06/30/26 - - 03/31/26 - 33.27 12/31/25 - 30.90 Net Margin 06/30/26 - - 03/31/26 - 32.43 12/31/25 - 28.80 Pre-Tax Margin 06/30/26 - - 03/31/26 - 40.47 12/31/25 - 35.80 Book Value 06/30/26 - - 03/31/26 - 1.68 12/31/25 - 2.01 Inventory Turnover 06/30/26 - - 03/31/26 - 0.97 12/31/25 - 1.13 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.51 12/31/25 - 0.16 Debt-to-Capital 06/30/26 - - 03/31/26 - 33.87 12/31/25 - 13.73

Powered by Zacks Investment Research ©